Construction and Screening of shRNA Expression Plasmids Targeting at cortactin Gene

YUAN Daiyue; SHAO Weibin; HAO Qingya; YAN Dongliang; ZHU Jianwei

doi:10.3971/j.issn.1000-8578.2015.10.007

Cancer Research on Prevention and Treatment > 2015 > 42(10): 984-987. > DOI: 10.3971/j.issn.1000-8578.2015.10.007

YUAN Daiyue, SHAO Weibin, HAO Qingya, YAN Dongliang, ZHU Jianwei. Construction and Screening of shRNA Expression Plasmids Targeting at cortactin Gene[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 984-987. DOI: 10.3971/j.issn.1000-8578.2015.10.007

Citation:

PDF (2346 KB)

Construction and Screening of shRNA Expression Plasmids Targeting at cortactin Gene

1. Department of General Surgery, Nantong First People's Hospital, Nantong 226311, China; 2. Department of General Surgery, Affiliated Hospital of Nantong University, Nantong 226311, China

More Information

Received Date: October 29, 2014
Revised Date: March 18, 2015

Graphical Abstract

Abstract

Abstract

Objective To construct short hairpin RNA (shRNA) expression plasmids targeting at the cortactin gene, and to screen the plasmid with the most knockdown efficiency. Methods Three pairs of shRNAs targeting at the cortactin gene were designed and synthesized. The shRNA expression plasmids (named pBSilence1.1-cortactin-shRNA1-3) were constructed and identified using restriction enzyme analysis and sequence analysis. The plasmids (pBSilence1.1-cortactin-shRNA1-3 and negative control plasmid) were then transfected into HepG2 cells via liposome. The transfection results were observed after 24h, and the cortactin mRNA expression was measured by reverse transcriptase-polymerase chain reaction(RT-PCR). Results The expression plasmids were confirmed by restriction enzyme analysis and sequence analysis. After the plasmid vector with green fluorescent protein was transfected to the cells, it was seen as a green fluorescent wave. RTPCR results showed that the cortactin mRNA expression in HepG2 cells of the three recombinant plasmids groups were decreased significantly compared with the negative control and blank control group(P＜0.05). The pBSilence1.1-cortactin-shRNA3 had the strongest knockdown efficiency compared with pBSilence1.1- cortactin-shRNA1 and pBSilence1.1-cortactin-shRNA2 groups(P＜0.05). Conclusion The constructed and screened shRNA expression plasmid targeting at the cortactin gene could suppress the cortactin mRNA expression in HepG2 cells significantly, which provides an experimental basis to study the effect of cortactin gene silencing on the biological behavior of liver cancer cells by RNA interference.
- Cortactin,
- Short hairpin RNA(shRNA),
- RNA interference,
- Liver cancer

FullText(HTML)

References (10)

References

[1]	Sung BH, Zhu X, Kaverina I, et al. Cortactin controls cell motility and lamellipodial dynamics by regulating ECM secretion[J]. Curr Biol, 2011, 21(17): 1460-9.
[2]	Kirkbride KC, Sung BH, Sinha S, et al. Cortactin: a multifunctional regulator of cellular invasiveness[J]. Cell Adh Migr, 2011, 5(2): 187-98.
[3]	Evans JV, Kelley LC, Hayes KE, et al. Further insights into cortactin conformational regulation[J]. Bioarchitecture, 2011, 1( 1): 21-3.
[4]	Nazari H, Khaleghian A, Takahashi A, et al. Cortactin, an actin binding protein, regulates GLUT4 translocation via actin filament remodeling[J]. Biochemistry(Mosc), 2011, 76(11): 1262-9.
[5]	Wei J, Zhao ZX, Li Y, et al. Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells[J]. World J Gastroenterol, 2014, 20(12): 3287-300.
[6]	Zhu JW, Ma LL, Huang BY, et al. A pivotal role of cortactin, a CTTN encoding protein, in endocytosis of human colon cancer[J]. Zhonghua Yi Xue Za Zhi, 2011, 91(6): 385-90. [朱建伟, 马利林, 黄宝玉, 等. 癌基因CTTN编码蛋白Cortactin与大肠癌细胞内吞作用的关系[J]. 中华医学杂志, 2011, 91(6): 385-90.]
[7]	MacGrath SM, Koleske AJ. Cortactin in cell migration and cancer at a glance[J]. J Cell Sci, 2012, 125(Pt 7): 1621-6.
[8]	Xiong Y, Wang AM, Guo W. Biological behavior of colorectal carcinoma Lovo cells after stable transfection survivin targeted shRNA plasmid expression vector[J].中华实用诊断与治疗杂志, 20 09, 23(8): 741-3. [熊英, 王爱民, 郭文. 导入靶向survivin基因的shRNA质粒表达载体对大肠癌细胞生物学行为的影响[J]. 中华实用诊断与治疗杂志, 2009, 23(8): 741-3.]
[9]	Shi J, Zhang QL, Ding YQ. Application of RNAi technology in respiratory tumour study[J]. Shi Yong Yi Xue Za Zhi, 2010, 26 (16): 3058-60. [石见, 张庆玲, 丁彦青. RNAi技术在呼吸系统肿瘤研究中的应用[J]. 实用医学杂志, 2010, 26(16): 3058-60. ]
[10]	Li XJ, Chen BH, Yao B, et al. Down-regulating UHRF1 expression could inhibit progression of hepatocellular carcinoma[J]. Zhong Liu Fang Zhi Yan Jiu, 2015, 42(7): 666-70. [ 李新建, 陈保华, 姚斌, 毛英. 下调UHRF1的表达在抑制肝癌进展中的作用[J]. 肿瘤防治研究, 2015, 42(7): 666-70.]

[1]	ZHAO Xiaole, QIAN Bo, SHAO Quan. Expression and Prognostic Value of Cuprotosis-related Genes in Liver Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(2): 140-145. DOI: 10.3971/j.issn.1000-8578.2023.22.0680
[2]	YANG Tingfang, WANG Li, ZHANG Yong. Expression of FOXO1 in Liver Cancer and Its Prognostic Significance: An Analysis Based on TCGA[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 774-781. DOI: 10.3971/j.issn.1000-8578.2021.21.0221
[3]	LI Bo, LYU Ming, ZHOU Shuai. Expression and Clinical Significance of lnc RNA HOXA11-AS in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2020, 47(8): 607-610. DOI: 10.3971/j.issn.1000-8578.2020.19.1503
[4]	YU Xia, JI Mingfang, CHENG Weimin, WU Biaohua. Situation and Problem on Screening of Liver Cancer in High-incidence Area of Xiaolan, Zhongshan City[J]. Cancer Research on Prevention and Treatment, 2016, 43(4): 287-290. DOI: 10.3971/j.issn.1000-8578.2016.04.010
[5]	Zhang Zhenni, Kuang Zhipeng, Yang Fan, Wu Jining. Differential Expression of Stem Cell Marker CK19 in Process of Chemical Carcinogenesis of Liver Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(10): 1188-1192. DOI: 10.3971/j.issn.1000-8578.2012.10.007
[6]	Xie Xinmei, He Yanfen, Zhang Hongliang. Effect of Cinobufacini on Bone Marrow Derived Dendritic Cells in Rat with Liver Cancer and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2012, 39(10): 1183-1187. DOI: 10.3971/j.issn.1000-8578.2012.10.006
[7]	SHE Shang-yang, LAN Xiu-wan, HE Min, WANG Qiu-yan. Effect of α1,3-fucosyltransferase-Ⅶ Gene Silence by RNA Interference on Cell Proliferation of Human Hepatocarcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2010, 37(05): 507-510. DOI: 10.3971/j.issn.1000-8578.2010.05.005
[8]	WU Jian-bing, FU Hua-qun, LIU An-wen, ZHANG Ji-xiang. BMP-2-siRNA Mediated Apoptosis and Proliferation of Human Hepatoma Cell Line SMMC7721[J]. Cancer Research on Prevention and Treatment, 2010, 37(05): 503-506. DOI: 10.3971/j.issn.1000-8578.2010.05.004
[9]	MAO Li-jun, ZHENG Jun-nian, ZHENG Hong-xiang, SUN Xiao-qing, CHEN Jia-cun. Antitumor Effect of Replication-competent Adenovirus Expressing Short Interference RNA Targeting Ki67 Gene on Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2007, 34(04): 262-265. DOI: 10.3971/j.issn.1000-8578.3255
[10]	PING Hao, ZHANG Jun-hui, CHEN Xiao-chun, LU Gong-cheng. Study on Inhibition of Growth and Proliferation in Prostate Cancer Cell by the shRNA of hTERT[J]. Cancer Research on Prevention and Treatment, 2007, 34(02): 128-131. DOI: 10.3971/j.issn.1000-8578.1535

Cited By

Get Citation

PDF

XML

Article views (1708) PDF downloads (502)

Turn off MathJax

Article Contents

Abstract

References

Construction and Screening of shRNA Expression Plasmids Targeting at cortactin Gene

Abstract

References

Related Articles

Catalog

Contact Us

Construction and Screening of shRNA Expression Plasmids Targeting at cortactin Gene

Abstract

References

Related Articles

Catalog

Contact Us

Export File

Citation

Format

Content